Karmanos Cancer Institute Adopts UroNav Technology to Diagnose Prostate Cancer

Karmanos Cancer Institute Adopts UroNav Technology to Diagnose Prostate Cancer
Urologists at Detroit’s Barbara Ann Karmanos Cancer Institute have switched to a more sophisticated technology for diagnosing prostate cancer: the UroNav Fusion Biopsy System. UroNav fuses 3D magnetic resonance imaging (MRI) pictures of the prostate with live ultrasound images to guide the biopsy procedure. The machine fuses images so they move and change in real time as urologists perform

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Chris O'Neill says:

    “We are better at finding cancers, and therefore better at determining the best treatment plan for each patient.”

    Doesn’t necessarily follow. PSA screening leads to finding lots of cancers but doesn’t save lives overall, not even from prostate cancer itself outside Sweden or the Netherlands. There needs to be a randomised controlled trial before anyone can claim a better outcome.

Leave a Comment

Your email address will not be published. Required fields are marked *